By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Fortress Biotech (Formerly Known As Coronado Biosciences) 

4365 Executive Drive
Suite 1500
San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a


Start Up

Company News
Fortress Biotech (CNDO) Subsidiary, Altamira Bio, Acquires NIH License And Cradas Relating To The Development Of N-Acetyl-D-Mannosamine (Mannac) For Rare Genetic Disorders 7/17/2015 7:20:55 AM
Fortress Biotech (CNDO) Reports Financial Results For The First Quarter 2015 Ended March 31, 2015 5/11/2015 8:37:25 AM
Coronado Biosciences (CNDO) Changes Its Name To Fortress Biotech 4/27/2015 7:57:51 AM
Coronado Biosciences (CNDO) Forms New Subsidiary, Diavax Biosciences, To Develop Novel Immunotherapies For Cytomegalovirus 4/2/2015 7:14:26 AM
Coronado Biosciences (CNDO) Announces Exclusive Licensing Agreement With Neupharma To Develop And Commercialize Novel Covalent 3rd Generation EGFR Inhibitors 3/19/2015 7:38:45 AM
New Company Mustang Therapeutics Formed by Coronado Biosciences (CNDO), City of Hope 3/19/2015 7:29:32 AM
Coronado Biosciences (CNDO) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 201 3/16/2015 7:53:29 AM
Coronado Biosciences (CNDO) Forms New Subsidiary, Checkpoint Therapeutics, To Develop Novel Immuno-Oncology Antibodies 3/4/2015 7:11:28 AM
Coronado Biosciences (CNDO) Closes $10 Million Private Placement Financing 3/3/2015 7:10:55 AM
Coronado Biosciences (CNDO) In-Licenses IV Tramadol, A Phase III Ready Asset, From Revogenex Ireland Ltd. 2/18/2015 7:40:51 AM